Stay updated on Palbociclib in Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Palbociclib in Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Palbociclib in Metastatic Breast Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant piece of information regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    0.5%
    Check dated 2025-07-04T13:15:22.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.4%
    Check dated 2025-06-20T06:38:59.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page has updated the number of study locations from 118 to 106 and revised the version from v2.16.2 to v2.16.3. Additionally, several hospitals in Germany, France, and the United States have been removed from the list of locations.
    Difference
    2%
    Check dated 2025-06-13T01:04:20.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-05T21:17:42.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.
    Difference
    0.5%
    Check dated 2025-05-29T16:22:21.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page has removed a detailed citation regarding a clinical trial on hormone-receptor-positive, HER2-negative metastatic breast cancer, which was previously included.
    Difference
    0.2%
    Check dated 2025-05-15T10:53:35.000Z thumbnail image

Stay in the know with updates to Palbociclib in Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Palbociclib in Metastatic Breast Cancer Clinical Trial page.